Current role
Nishant Saxena
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Nishant Saxena
Corbus Pharmaceuticals Holdings, Inc. reported in an 8-K filed May 21, 2026 that Nishant Saxena was appointed Chief Business Officer. Corbus Pharmaceuticals Holdings, Inc. reported in an 8-K filed May 21, 2026 that Nishant Saxena was appointed Chief Business Officer, effective May 21, 2026.
“Corbus also announced today the appointment of former Evercore Managing Director Nishant Saxena as the Company's first Chief Business Officer”
“On May 21, 2026, the Company issued a press release announcing the appointment of Mr. Saxena as Chief Business Officer of the Company, and that the Company’s management team will host a conference call and webcast on Tuesday, May 26, 2026 at 8:00 a.m. EDT to discuss clinical data from its Phase 1/2 study of CRB-701.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-05-21–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Corbus Pharmaceuticals Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Yuval Cohen CEO, Board Member
- Alan Holmer Chairman, Board Member
- Sean Moran CFO
- Ian Hodgson COO
- Anne Altmeyer Board Member
- Anne Altmeyer, Ph.D., MBA, MPH Board Member
- Avery W. Catlin Board Member
- Brent Pfeiffenberger Board Member
- George S. Golumbeski Board Member
- John Jenkins Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.